June 19, 2016 – We Celebrate reaching over One Million e-Readers @PharmaceuticalIntelligence.com

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

 

1,000,126 e-Readers

6/19/2016 @8:30PM EST

PRESS RELEASE 6/20/2016

ReleaseWire – Leaders in Pharmaceutical Business Intelligence (LBPI Group), launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), has reached over 1 million unique site visits, with approximately 30,000 monthly views, 1,600 followers and 300 sites linking into the journal, including ncbi.nlm.nih.gov, Nature.com , commons.wikipedia.org, dx.doi.org, NEJM, personalizedmedicine.partners.org, cancer.gov, medscape.com, masspec.scripps.edu, and sciencedirect.com.

Leaders in Pharmaceutical Business Intelligence Group is a scientific, medical and business multi-expert authoring platform in several domains: life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at its website http://pharmaceuticalintelligence.com for curation and reporting on innovations in biomedical and biological sciences, healthcare economics, pharmacology, pharmaceutical research & medicine. The Open Access Online Scientific Journal currently contains 2,521 annotated & curated articles in over 300 categories of research in Biotech, Life Sciences and Medicine.

The LBPI Group venture publishes a BioMedical Series of e-Books available on mobile platforms (current & future titles at http://pharmaceuticalintelligence.com/biomed-e-books/.)  It also represents a dozen Biotechnology and Medical Devices startups in Private Equity Funding and an IP Development Group, DrugDiscovery@LPBI Group, and Medical 3D Printing.

The venture’s expertise in Real-Time Scientific Conferences Coverage, using social media and creating  electronic conference proceedings posted on the Internet, has included the following events as well as others: Harvard’s Personalized Medicine Conferences in 2015 & 2016, CHI Discovery On Target 2016, MassBio 2015 & 2016, MassBioAnnual Meeting 2014, BioIT World, April 30, 2014, Koch Institute for Integrative Cancer Research @MIT – Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014, Gabbay Award Lectures in Biotechnology and Medicine – Hosted by Rosenstiel Basic Medical Sciences Research Center, Brandeis University, October 27, 2014, 10th Annual Personalized Medicine Conference at the Harvard Medical School, November 12-13, 2014, and two Biotech Investment Conferences in 2014, one in NYC and one in Basel by Sachs Associates of London.

Source: Leaders in Pharmaceutical Business Intelligence
Posted Monday, June 20, 2016 at 11:45 AM CDT – Permalink

SOURCE

http://www.sbwire.com/press-releases/leaders-in-pharmaceutical-business-intelligence-online-journal-has-hit-1-million-viewers-699913.htm#.V35E9FrfWa4.twitter

Content

4,716 Scientific Articles

487 Research Categories in Life Sciences & Medicine

9,286 Scientific Tags

7,251 Scientific Comments

 

Followers (includes Publicize)

2,116 e-Journal Subscribers

626 Blog

721 Twitter

699 Facebook

71 Tumblr

Our DOMAINS in e-Scientific Media

I.    Pharmaceutical: Biologics, Small Molecules, Diagnostics

II.  Life Sciences: Genomics and Cancer Biology

III.  Patient-centered Medicine: Focus on #1: Cardiovascular, #2: Cancer, #3: Physiology Metabolomics, Immunology

IV.  Biomedicine, BioTech, and MedTech (Medical Devices)

V.   HealthCare: Patient-centered Medicine and Personalized/Precision Medicine

 

Open Access Online Journal

http://www.pharmaceuticalIntelligence.com

is a scientific, medical and business, multi-expert authoring environment for information syndication in several domains of Life Sciences, Medicine, Pharmaceutical and Healthcare Industries, BioMedicine, Medical Technologies & Devices. Scientific critical interpretations and original articles are written by PhDs, MDs, MD/PhDs, PharmDs, Technical MBAs as Experts, Authors, Writers (EAWs) on an Equity Sharing basis.

All articles in the Journal are written by Experts, Authors, Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. 

Articles that have been published on the Open Access Online Scientific Journal, since April 2012 are selected by Domain Expert Editors for creation of original electronic Table of Contents (eTOCs).

 

Author		Views on 7/6/2016
Aviva Lev-Ari, PhD, RN		274,480
larryhbern		185,056
tildabarliya		41,062
sjwilliamspa		31,450
Dror Nir		21,666
Dr. Sudipta Saha		18,540
ritusaxena		14,507
Demet Sag, Ph.D., CRA, GCP		10,937
aviralvatsa		7,765
zraviv06		6,710
zs22		3,531
anamikasarkar		3,140
pkandala		2,082
Alan F. Kaul, PharmD., MS, MBA, FCCP		1,894
danutdaagmailcom		1,847
Aashir Awan, Phd		1,706
megbaker58		1,380
jdpmd		1,229
Irina Robu		779

See Our e-Books on Amazon.com

https://pharmaceuticalintelligence.com/biomed-e-books/

LPBI Group has Three Enterprise Types and Five Subsidiaries

We are in Knowledge-based Informational Services

 

• Subsidiary 1: e-Scientific Content Creation and Digital Media

Line-of-Business #1:

Open Access OnLine Scientific Journal  +1 Million e-Readers on 6/19/2016, 2,116 Subscribers, 4,716 Scientific Articles, ~7,251 Comments by Scientists

Line-of-Business #2:

BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 7 e-Books in 2016

Line-of-Business #3:

Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events

Line-of-Business #4:

Audio-Podcast Series in Medicine, 5 tracks

&

• Subsidiary 4: Intellectual Property Asset Management

Line-of-Business #5:

Representation of US Patent Holders for Commercialization, Licensing and Partnerships

We are in Research Biotech Businesses

 

• Subsidiary 3: R&D in 3D BioPrinting

Line-of-Business #6:

Tissue Engineering, Gene Therapy: Stem Cells & Gene Editing, Medical Devices: Product Concepts

&

• Subsidiary 5: Pharmaceutical R&D: Drug Discovery and Drug-Devices Development

Line-of-Business #7:

• Drug Discovery with 3D BioPrinting

Line-of-Business #8:

• Drug Delivery System – One solution for many agents for many indications

 

We are in Business Financial Transactions (No Securities Traded)

 

• Subsidiary 2: Funding Early Stage Businesses, IP Licensing and Business Partnerships:

Line-of-Business #9:

Early Stage Venture Funding

Corporate Clients for Our Services

https://pharmaceuticalintelligence.com/joint-ventures/corporate-clients-for-our-services/

 

• MEDICAL DEVICES
• Pharmaceutical Informational PLATFORMS
• INVENTIONS IN BIOLOGICS